Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
Journal of Scleroderma and Related Disorders
|
February 2, 2019
Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report
John D Pauling, Tracy M Frech, Michael Hughes, et al.
The European Respiratory Journal
|
August 7, 2025
Pericardial Effusions And Sotatercept Therapy in Pulmonary Arterial Hypertension: A Multicenter Real-World Experience
Sandeep Sahay, Nelson Villasmil Hernandez, Yassmin Al Aaraj, et al.
Journal of Scleroderma and Related Disorders
|
March 26, 2019
An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups
Murray Baron, Bashar Kahaleh, Elana J Bernstein, et al.
The Lancet. Rheumatology
|
April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study
Monique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 3, 2021
ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements
Maria M Crespo, Tamara Claridge, Robyn T Domsic, et al.
Seminars in Arthritis and Rheumatism
|
April 9, 2014
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study
Vivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease
Shervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Arthritis Care & Research
|
August 29, 2013
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry
Lorinda Chung, Robyn T Domsic, Bharathi Lingala, et al.
Respiratory Research
|
January 9, 2023
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Franck F Rahaghi, Vivien M Hsu, Robert J Kaner, et al.
The Journal of Rheumatology
|
October 3, 2018
Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry
Vivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
Journal of Scleroderma and Related Disorders
|
February 2, 2019
Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report
John D Pauling, Tracy M Frech, Michael Hughes, et al.
The European Respiratory Journal
|
August 7, 2025
Pericardial Effusions And Sotatercept Therapy in Pulmonary Arterial Hypertension: A Multicenter Real-World Experience
Sandeep Sahay, Nelson Villasmil Hernandez, Yassmin Al Aaraj, et al.
Journal of Scleroderma and Related Disorders
|
March 26, 2019
An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups
Murray Baron, Bashar Kahaleh, Elana J Bernstein, et al.
The Lancet. Rheumatology
|
April 3, 2025
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study
Monique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
September 3, 2021
ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements
Maria M Crespo, Tamara Claridge, Robyn T Domsic, et al.
Seminars in Arthritis and Rheumatism
|
April 9, 2014
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study
Vivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 22, 2020
Predictive Significance of Serum Interferon-Inducible Protein Score for Response to Treatment in Systemic Sclerosis-Related Interstitial Lung Disease
Shervin Assassi, Ning Li, Elizabeth R Volkmann, et al.
Arthritis Care & Research
|
August 29, 2013
Survival and predictors of mortality in systemic sclerosis-associated pulmonary arterial hypertension: outcomes from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry
Lorinda Chung, Robyn T Domsic, Bharathi Lingala, et al.
Respiratory Research
|
January 9, 2023
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Franck F Rahaghi, Vivien M Hsu, Robert J Kaner, et al.
The Journal of Rheumatology
|
October 3, 2018
Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry
Vivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Page
of 10